David A. Siegel Viatris Inc Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Viatris Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 163,300 shares of VTRS stock, worth $1.65 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
163,300
Previous 311,200
47.53%
Holding current value
$1.65 Million
Previous $2.71 Million
46.2%
% of portfolio
0.0%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding VTRS
# of Institutions
1,133Shares Held
972MCall Options Held
7.62MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA145MShares$1.47 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$936 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD78.8MShares$796 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az66.4MShares$670 Million3.26% of portfolio
-
State Street Corp Boston, MA55.3MShares$558 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $12.2B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...